Phase I study of larotaxel administered as a 1-h intravenous infusion every 3 weeks to Japanese patients with advanced solid tumours (Q40389914)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of larotaxel administered as a 1-h intravenous infusion every 3 weeks to Japanese patients with advanced solid tumours |
scientific article |
Statements
1 reference
Phase I study of larotaxel administered as a 1-h intravenous infusion every 3 weeks to Japanese patients with advanced solid tumours (English)
1 reference
Narikazu Boku
1 reference
Nobuyuki Yamamoto
1 reference
Hironobu Minami
1 reference
13 May 2009
1 reference
1 reference
65
1 reference
1
1 reference
129-136
1 reference
Identifiers
1 reference
1 reference